Inovio Pharmaceuticals Inc (0A43)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 35.37M | 42.22M | 30.48M | 4.11M | 7.41M | 1.78M | 10.26M | 832k |
営業利益 | -76.13M | -91.63M | -96.08M | -114.2M | -87.53M | -301.77M | -269.47M | -143.17M |
税引前収入 | -73.74M | -88.21M | -94.8M | -120.81M | -162.89M | -303.22M | -277.65M | -135.12M |
純利益 | -73.74M | -88.21M | -96.97M | -119.36M | -166.41M | -303.66M | -279.82M | -135.12M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.994 | -0.975 | -0.996 | -1.176 | -0.89 | -1.396 | -1.105 | -0.495 |
EBIT | -75.13M | -90.63M | -96.08M | -113.7M | -83.52M | -301.43M | -273.34M | -147.88M |
EBITDA | -73.04M | -88.16M | -91.08M | -109.54M | -83.94M | -298.21M | -265.28M | -129.89M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約